FDA Adds Warning to Ozempic Label About Risk for Blocked Intestines
By Cara Murez HealthDay Reporter
Medically reviewed by Drugs.com. Last updated on Oct 10, 2024.
WEDNESDAY, Sept. 27, 2023 -- Ozempic, a type 2 diabetes drug that has increasingly been used to help with weight loss, will now be labeled as having the potential to block intestines.
The U.S. Food and Drug Administration recently made the label update for the drug made by Novo Nordisk, without directly citing Ozempic as the cause for this condition.
"Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure," the label reads.
The side effect, known by the medical term “ileus,” is also listed on labels for the weight-loss drug Wegovy, also made by Novo Nordisk, and in the diabetes medication Mounjaro, made by Eli Lilly, CBS News reported.
Both Ozempic and Wegovy are known generically as semaglutide. Among more than 8,500 reports of gastrointestinal disorders after using semaglutide medications through June 30, ileus is mentioned in 33 cases, including two deaths, CBS News reported.
The two pharmaceutical companies that make these medications are both being sued for claims that the drugs can cause a similar health issue known as gastroparesis, or stomach paralysis, CBS News reported.
Sources
- CBS News
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted September 2023
Read this next
Body Fat Analysis, Waist Size Better Than BMI For Assessing Health
FRIDAY, June 27, 2025 — A person’s body fat percentage provides a better estimate of their risk for early death than their body mass index (BMI), a new study...
Online Videos For Kids Rife With Junk Food Messaging
THURSDAY, June 26, 2025 — Kids watching YouTube videos are being hammered with messages promoting junk food like candy, sugary drinks, fast food and sweet or salty snacks, a...
Monthly Obesity Shot, MariTide, Shows Big Weight Loss in Trial
WEDNESDAY, June 25, 2025 — Alternatives to weekly injections of weight-loss drugs may on the way. A monthly dose of a new drug called MariTide helped participants in a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.